Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Anatomy Item Literature (446) Expression Attributions Wiki
XB-ANAT-1579

Papers associated with

Limit to papers also referencing gene:
???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Characterization of a novel α-conotoxin from conus textile that selectively targets α6/α3β2β3 nicotinic acetylcholine receptors., Luo S., J Biol Chem. January 11, 2013; 288 (2): 894-902.


Fast silencing reveals a lost role for reciprocal inhibition in locomotion., Moult PR., Neuron. January 9, 2013; 77 (1): 129-40.                


Toxicity of the synthetic polymeric 3-alkylpyridinium salt (APS3) is due to specific block of nicotinic acetylcholine receptors., Grandič M., Toxicology. January 7, 2013; 303 25-33.


Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate., Dong Q., Biol Pharm Bull. January 1, 2013; 36 (2): 268-75.


The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface., Wilson MC., PLoS One. January 1, 2013; 8 (11): e78654.          


A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins., Peigneur S., FASEB J. December 1, 2012; 26 (12): 5141-51.


Inhibitory effect of the recombinant Phoneutria nigriventer Tx1 toxin on voltage-gated sodium channels., Silva AO., Biochimie. December 1, 2012; 94 (12): 2756-63.


The non-competitive acetylcholinesterase inhibitor APS12-2 is a potent antagonist of skeletal muscle nicotinic acetylcholine receptors., Grandič M., Toxicol Appl Pharmacol. December 1, 2012; 265 (2): 221-8.


Mixed antagonistic effects of the ginkgolides at recombinant human ρ1 GABAC receptors., Huang SH., Neuropharmacology. November 1, 2012; 63 (6): 1127-39.                      


Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels., Schmidt C., Naunyn Schmiedebergs Arch Pharmacol. October 1, 2012; 385 (10): 1003-16.


Cartilage on the move: cartilage lineage tracing during tadpole metamorphosis., Kerney RR., Dev Growth Differ. October 1, 2012; 54 (8): 739-52.                      


Differentiating enantioselective actions of GABOB: a possible role for threonine 244 in the binding site of GABA(C) ρ(1) receptors., Yamamoto I., ACS Chem Neurosci. September 19, 2012; 3 (9): 665-73.


Design of bioactive peptides from naturally occurring μ-conotoxin structures., Stevens M., J Biol Chem. September 7, 2012; 287 (37): 31382-92.


N3,N7-diaminophenothiazinium derivatives as antagonists of α7-nicotinic acetylcholine receptors expressed in Xenopus oocytes., Sadek B., Pharmacol Res. September 1, 2012; 66 (3): 213-8.


Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5., Arakawa H., Biopharm Drug Dispos. September 1, 2012; 33 (6): 332-41.


Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule., Garg V., J Gen Physiol. September 1, 2012; 140 (3): 307-24.                            


Azemiopsin from Azemiops feae viper venom, a novel polypeptide ligand of nicotinic acetylcholine receptor., Utkin YN., J Biol Chem. August 3, 2012; 287 (32): 27079-86.          


Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A., Kulzer M., Biochem Biophys Res Commun. July 27, 2012; 424 (2): 315-20.


Inhibitory effects of dextrorotatory morphinans on the human 5-HT(3A) receptor expressed in Xenopus oocytes: Involvement of the N-terminal domain of the 5-HT(3A) receptor., Lee BH., Eur J Pharmacol. July 5, 2012; 686 (1-3): 41-9.


Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors., McClymont DW., Eur J Pharmacol. July 5, 2012; 686 (1-3): 22-31.                  


Mutation conferring apical-targeting motif on AE1 exchanger causes autosomal dominant distal RTA., Fry AC., J Am Soc Nephrol. July 1, 2012; 23 (7): 1238-49.


A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors., Favreau P., Br J Pharmacol. July 1, 2012; 166 (5): 1654-68.


Probing the Xenopus laevis inner ear transcriptome for biological function., Powers TR., BMC Genomics. June 8, 2012; 13 225.            


18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels., Du YM., Acta Pharmacol Sin. June 1, 2012; 33 (6): 752-60.            


Pharmacological characterization of the Haemonchus contortus GABA-gated chloride channel, Hco-UNC-49: modulation by macrocyclic lactone anthelmintics and a receptor for piperazine., Brown DD., Vet Parasitol. April 30, 2012; 185 (2-4): 201-9.


TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation., Seyler C., Br J Pharmacol. March 1, 2012; 165 (5): 1467-75.


Understanding ciliated epithelia: the power of Xenopus., Werner ME., Genesis. March 1, 2012; 50 (3): 176-85.        


Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid., Costa BM., Neuropharmacology. March 1, 2012; 62 (4): 1730-6.


[Mg(2+) inhibits ATP-activated current mediated by rat P2X4 receptors expressed in Xenopus oocytes]., Peng F., Sheng Li Xue Bao. February 25, 2012; 64 (1): 75-81.


The inhibitory potency of local anesthetics on NMDA receptor signalling depends on their structural features., Gronwald C., Eur J Pharmacol. January 5, 2012; 674 (1): 13-9.


Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop., El-Ajouz S., Br J Pharmacol. January 1, 2012; 165 (2): 390-400.          


Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine., Damaraju VL., Nucleosides Nucleotides Nucleic Acids. January 1, 2012; 31 (3): 236-55.


γ-Aminobutyric acid transporter 2 mediates the hepatic uptake of guanidinoacetate, the creatine biosynthetic precursor, in rats., Tachikawa M., PLoS One. January 1, 2012; 7 (2): e32557.        


Cloning and characterization of a P2X receptor expressed in the central nervous system of Lymnaea stagnalis., Bavan S., PLoS One. January 1, 2012; 7 (11): e50487.                


Chromatin modification by PSC occurs at one PSC per nucleosome and does not require the acidic patch of histone H2A., Lo SM., PLoS One. January 1, 2012; 7 (10): e47162.                  


A molecular switch driving inactivation in the cardiac K+ channel HERG., Köpfer DA., PLoS One. January 1, 2012; 7 (7): e41023.          


Complement fragment C3a controls mutual cell attraction during collective cell migration., Carmona-Fontaine C., Dev Cell. December 13, 2011; 21 (6): 1026-37.                


Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors., García-Colunga J., Neuropharmacology. December 1, 2011; 61 (8): 1202-9.


The influence of calcium ions on nickel modulation of NMDA receptor currents., Gavazzo P., Metallomics. December 1, 2011; 3 (12): 1376-83.


Functional characterization and high-throughput screening of positive allosteric modulators of α7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cells., Gopalakrishnan SM., Assay Drug Dev Technol. December 1, 2011; 9 (6): 635-45.


Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1., Raphemot R., Front Pharmacol. November 30, 2011; 2 75.              


Postsynaptic TRPC1 function contributes to BDNF-induced synaptic potentiation at the developing neuromuscular junction., McGurk JS., J Neurosci. October 12, 2011; 31 (41): 14754-62.                


Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor., Lummis SC., J Pharmacol Exp Ther. October 1, 2011; 339 (1): 125-31.


Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide., Garg V., Mol Pharmacol. October 1, 2011; 80 (4): 630-7.


Split-inteins for simultaneous, site-specific conjugation of quantum dots to multiple protein targets in vivo., Charalambous A., J Nanobiotechnology. September 15, 2011; 9 37.              


Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport., Svoboda M., Biomed Pharmacother. September 1, 2011; 65 (6): 417-26.


Importance of position 8 in μ-conotoxin KIIIA for voltage-gated sodium channel selectivity., Van Der Haegen A., FEBS J. September 1, 2011; 278 (18): 3408-18.


Effects of the histamine H(1) receptor antagonist hydroxyzine on hERG K(+) channels and cardiac action potential duration., Lee BH., Acta Pharmacol Sin. September 1, 2011; 32 (9): 1128-37.                  


Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state., Larsen AP., Biophys J. August 17, 2011; 101 (4): 818-27.


External Cu2+ inhibits human epithelial Na+ channels by binding at a subunit interface of extracellular domains., Chen J., J Biol Chem. August 5, 2011; 286 (31): 27436-46.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 ???pagination.result.next???